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ABSTRACT
The rules of engagement between zinc finger tran-
scription factors and DNA have been partly defined
by in vitro DNA-binding and structural studies, but
less is known about how these rules apply in vivo.
Here, we demonstrate how a missense mutation
in the second zinc finger of Kru¨ppel-like factor-1
(KLF1) leads to degenerate DNA-binding specificity
in vivo, resulting in ectopic transcription and ane-
mia in the Nan mouse model. We employed ChIP-seq
and 4sU-RNA-seq to identify aberrant DNA-binding
events genome wide and ectopic transcriptional con-
sequences of this binding. We confirmed novel se-
quence specificity of the mutant recombinant zinc
finger domain by performing biophysical measure-
ments of in vitro DNA-binding affinity. Together, these
results shed new light on the mechanisms by which
missense mutations in DNA-binding domains of tran-
scription factors can lead to autosomal dominant dis-
eases.
INTRODUCTION
Zinc finger (ZF)-containing proteins (ZFPs) are the largest
class of proteins encoded by the human genome (1). The
C2H2-ZF subfamily is the most common. While some
members function as RNA-binding or protein-binding
modules, the majority are thought to function as DNA-
binding modules. These have been the focus of extensive in
vitro studies, both experimental and computational, in an
effort to better understand the sequence specificity encoded
by each ZF; i.e. the DNA-interaction code (2–4). This code
underpins the ability to design artificial sequence specific
ZFPs for manipulation of gene expression in vivo (5,6).
Arguably, most is known about the transcription fac-
tors (TFs) with three tandem C2H2 type ZFs; i.e. the re-
lated Egr (also known as Krox and Zif), Sp and Klf fami-
lies (5). The current model for DNA binding is based pri-
marily on structural studies of EGR1, SP1 and KLF4 (7–
10); Four key residues located relative to the start of the
C-terminal -helix (−1, +2, +3 and +6) of each ZF medi-
ate nucleotide contact. Residues at −1, +3 and +6 bind to
consecutive nucleotides and the residue at +2 makes con-
tact with the opposite strand or plays an indirect role in
binding (8–13). Thus, a single ZF essentially confers∼3 nu-
cleotide sequence specificity based on a code defined by the
amino acids at positions −1, +3, +6 and to a lesser extent,
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+2 (14). Based on this code each ZF in KLF1 recognizes a
triplet nucleotide sequence that together form KLF1’s cog-
nate 9 bp binding motif, CCM-CRC-CCN (15,16). In fact,
KLFs and SP family proteins actually make direct con-
tact with the opposite G-rich strand of DNA (8–14); i.e.
NGG-GYG-KGG. We have employed this G-rich strand
nomenclature in the figures and text from hereon. Based on
genome wide ChIP-seq data either a T or C at position 5
(A or G on C-rich strand) is permissive for KLF1, KLF2,
KLF3, KLF4, KLF5 and KLF11 DNA binding (17–22).
Indeed, all SP/KLFs studied to date bind an identical mo-
tif in vivo.
Many KLFs are expressed broadly, but KLF1 is re-
stricted to the erythroid lineage (15,23).Klf1 nullmice die by
E14.5 due to disruption of the second (or definitive) wave of
erythropoiesis (24,25). Detailed transcriptome and ChIP-
seq studies showed KLF1 directly regulates nearly all as-
pects of erythroid differentiation, including iron procure-
ment, heme biosynthesis, globin production, cytoskeletal
structure and the cell cycle (26,27). It functions primarily
as a transcriptional activator in vivo (28), but can function
as a repressor in some contexts (29).
The neonatal anemia (Nan) mouse carries a point-
mutation in Klf1 leading to a conservative amino acid
change (Glu339Asp; position +3 relative to the -helix) in
ZF2 (30). This mutation leads to semi-dominant hemolytic
anemia that persists throughout life and is transferable to
wild type recipients via bone marrow transplantation; i.e. it
is cell autonomous (30–32). HeterozygousNanmice display
hallmarks of hereditary spherocystosis and thalassemia,
with splenomegaly, iron deposition in the liver and spleen,
abnormal erythrocyte morphology and elevated zinc pro-
toporphyrin (30,32). We previously showed Glu339Asp re-
sults in reduced affinity at endogenousKLF1 target sites for
which position 5 is an adenine, such as at theHbb gene pro-
moter and E2f2 enhancer, but not where position 5 is a gua-
nine, such as at theCdkn1a (p21) enhancer (30). Bindingwas
tightly associated with expression of these genes. This po-
tentially creates two categories of binding sites/target genes
across the genome with respect to wild type and Nan ver-
sions of KLF1: (i) sites that are co-occupied by both KLF1
and Nan-KLF1 (Category I sites) and (ii) sites which are
bound only by KLF1 (Category II sites). However, this hy-
pomorphic model of Nan-KLF1 biochemical function can-
not fully explain the dominant phenotype of heterozygous
Nan mice, as it would predict less disease severity than that
generated by a complete loss of function allele; in fact, the
opposite is true. Surprisingly, homozygous Nan mice die
much earlier in gestation (at E10-11) than Klf1 null mice
(24–25,30,32–33). Klf1+/− mice (and humans) display no
overt phenotype. Thus, the Nan mutation represents a rare
class of mutation whereby the resulting phenotype is more
severe than a loss-of-function mutation. This is particularly
remarkable given the conservative glutamate to aspartate
change.
In this study, we test the hypothesis that theNanmutation
confers aberrant DNA-binding specificity that is detrimen-
tal to cell viability. Using ChIP-seq we show Nan-KLF1
binds promiscuously to degenerate motifs at genomic loci
not normally occupied by wild-type KLF1. Using a sensi-
tive RNA labeling approach (4sU) combined with RNA-
seq, we show Nan drives expression of a corrupted tran-
scriptome that is detrimental to erythroid cell survival.
This study provides insight into how an unexpected neo-
morphic function can occur in ZFPs when loss of DNA-
binding specificity leads to DNA-binding promiscuity. To
our knowledge this is the first description of this disease
mechanism. Our work suggests a one to one interaction
between amino acid residues at −1, +3 and +6 with sin-
gle nucleotides in the recognition motif is an oversimplifi-
cation of the binding mechanism. Rather, we suggest the
amino acid at the +3 position can indirectly influenceDNA-
binding affinity and specificity between the −1, +2 residues
and DNA.
METHODS
Detailed information of protocols and reagents are further
described in Supplementary Material.
ChIP-seq
K1-ER and K1-NanER cells were generated from an im-
mortalized Klf1−/− fetal liver cell line (K1) by retrovi-
ral transfection with plasmids containing ER™ fusions of
KLF1 and Nan-KLF1 as described previously (34). Three
clonally independent K1-ER and K1-NanER cell lines (1
× 107 cells of each) were induced with 2 mM tamoxifen
(or ethanol control) for 3 h before crosslinking with 1%
formaldehyde. ChIPwas performedwith a rabbit polyclonal
antibody raised against the N-terminal domain of KLF1
(24). Enriched DNA samples were validated by qPCR and
pooled prior to generating Ion Torrent fragment libraries.
RNA-seq
Total RNA was collected from three independent biolog-
ical samples of Klf1Nan/+ and wild-type mouse fetal liver
(E14.5). Illumina TruSeq Stranded mRNA libraries were
generated from globin mRNA-cleared samples as previ-
ously described. Replicate parental cell lines (K1) and two
clonally independentK1-ER andK1-NanER cell lines were
incubated with 2 mM tamoxifen and 500 M 4sU (to label
newly synthesized RNA) for 1 h prior to isolation of 4sU-
labeled RNA as described previously (35). Purified 4sU-
labeled RNA was used to generate Ion Xpress™ Plus frag-
ment libraries.
Protein–DNA binding assays
Purified recombinant ZF’s of KLF1 and Nan-KLF1 (600
nM) were hybridized with 32P-labeled oligos (5 nM) listed
in Supplementary Table S7 for electromagnetic shift assay
(EMSA) as previously described (36). Fluorescence polar-
ization assays were performed using 2 nM Fluorescein la-
beled probes (Supplementary Table S7) as previously de-
scribed (37,38).
Structural modeling
Protein structure visualization was performed using the
UCSF Chimera software (39) based on the structure of
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KLF4 bound to DNA (PDB ID:2WBU) (8). The Nan mu-
tation was modeled from a backbone-dependent rotamer li-
brary (40).
RESULTS
Fetal liver erythroid cells fromKlf1Nan/+mice display an aber-
rant transcriptome
To identify how the Nan mutation disrupts erythropoiesis,
we performed mRNA sequencing (RNA-seq) on Klf1Nan/+
versus wild-type fetal livers (n = 3 per group). We ob-
tained >35 million reads for each sample and performed
differential expression (DE) analysis using the Tuxedo Suite
pipeline (41). After filtering (see Materials and Methods),
we found 598 upregulated and 195 downregulated genes
in Klf1Nan/+ compared to wild type fetal liver (Figure
1A). Upon comparison with differentially expressed genes
(DEGs) in Klf1−/− fetal liver (550 upregulated and 628
downregulated (28), it is striking that the DEGs upregu-
lated in theKlf1Nan/+ fetal liver have little overlapwith either
of the Klf1−/− categories, suggesting a high level of ectopic
expression. There was a small set of just 190 shared DEGs
between data sets, and a quarter of these responded in op-
posing directions. This suggests Nan-KLF1 is both hypo-
morphic with respect to some KLF1 target genes and neo-
morphic, since many non-KLF1 target genes are activated
or repressed in Klf1Nan/+ fetal liver.
To explore the possible functions of the Klf1Nan/+ and
Klf1−/− DEGs, we performed gene ontology (GO) anal-
ysis using DAVID (42). We found the majority of DEGs
from Klf1Nan/+ fetal liver are not normally associated with
hematopoietic functions (Figure 1B), which is consistent
with a neomorphic function for the Nanmutation. The full
list of genes dysregulated inKlf1Nan/+ FL is provided in Sup-
plementary Table S1.
An in vitromodel of theNanmutation mimics the in vivo phe-
notype
We could not obtain definitive erythroid cells in which only
the Nan mutation is present, since Klf1Nan/Nan mice die at
∼E10.5 (33). Also, ChIP-seq in primary fetal liver cells
from Klf1Nan/+ mice would be difficult to interpret, since
we would not be able to tell whether the signal was from
the wild-type or mutant KLF1 binding to DNA, or both.
We needed a ‘cleaner’ system if we were to compare the
sites occupied by KLF1 versus Nan-KLF1, one in which
we could examine the transcriptional consequences of bind-
ing events without competition for binding. To this end, we
developed an in vitro model of the Nan mutation using a
Klf1 null erythroid cell line (K1) generated from Klf1−/−
E14.5 FL (34). Retroviruses consisting of either a Nan or
wild type Klf1 transgene fused to a modified Estrogen Re-
ceptor (ERTM) were introduced into K1 cells to generate
stable cell lines, which we will refer to as K1-ER and K1-
NanER cells (Figure 2A). Tamoxifen-inducible nuclear lo-
calization and equivalent expression amongst independent
clones of each construct was confirmed byWestern blotting
(Supplementary Figure S1).
We have previously shown that K1-ER cells replicate
many of the processes involved in terminal erythroid differ-
entiation such as hemoglobinization (34), chromatin con-
densation and activation of KLF1 target genes (e.g. Hbb-
b1, Ahsp and Dmnt) (43,44). In contrast, K1-NanER cell
lines make limited amounts of hemoglobin upon tamoxifen
induction (Figure 2B and C) and activateHbb-b1 and Ahsp
∼10-fold and ∼30-fold less than for K1-ER cells compared
to parental K1 cells (Figure 2D). These results are consis-
tent with a hypomorphic function for the Nan-KLF1 pro-
tein. Proliferation is halted but viability is maintained upon
KLF1 induction in K1-ER cells, presumably via direct up-
regulation of cell cycle inhibitors such as Cdkn2c (p18) (45)
andCdkn1a (46) (Figure 2E).However,K1-NanER cells ex-
hibit rapid loss of viability within the first 24 h following in-
duction. This suggests that Nan-KLF1 is somehow toxic to
erythroid cells.
The Nan mutation confers altered DNA-binding specificity
We hypothesized that the Nan mutation would lead to
loss of DNA-binding affinity through destabilization of the
ZF2-DNA interaction. Indeed, we previously reported re-
duced Nan-KLF1 binding to some established KLF1 tar-
get sites in vitro by EMSA (30). We performed ChIP with 3
clonally independent K1-NanER and K1-ER cell lines fol-
lowing induction with tamoxifen for 3 h and confirmed in
vivo occupancy at validated KLF1 binding sites in the in-
tronic enhancer of E2f2 (47) and the promoter of Ahsp (45)
for both KLF1 and Nan-KLF1 (Figure 3A and B). It is dif-
ficult to quantify independent ChIP experiments but com-
parison to input DNA provides some idea of efficiency.
We sequenced fragment libraries generated from ChIP
and input DNA samples to determine genome-wide Nan-
KLF1 versus KLF1 occupancy (see Materials and Meth-
ods). In brief, uniquely mapped reads were used for peak
calling byMACS2 (48) and declared peaks were filtered and
ranked based on fold enrichment (>30-fold compared with
input) and a low false-discovery rate (FDR < 0.1%). This
yielded a list of high-confidence ChIP-seq peaks: 2758 in
K1-NanER cells and 5326 in K1-ER cells (Figure 3C). Sup-
plementary Table S2 lists the top 30 peaks for each ranked
by fold enrichment and the entire lists can be found in Sup-
plementary Table S3 and S4. Although some Nan-KLF1
occupied sites were also bound by KLF1 (1057), the ma-
jority were not. Also, fewer unique Nan-KLF1 peaks than
KLF1 peaks overlap DNase I hypersensitivity sites (DHS)
from erythroid cells (∼45% cf. ∼66%) (Figure 3C) (49,50).
This observation suggests Nan-KLF1 binds to some ge-
nomic sites that are not normal erythroid enhancers or pro-
moters. Yet, Nan-KLF1 peaks were distributed similarly to
KLF1 peaks with respect to the nearest transcriptional start
site (TSS), being located primarily within introns, promot-
ers or distally (Supplementary Figure S2A).
De novo motif discovery using MEME (51) identified
highly enriched motifs for both KLF1 and Nan-KLF1
(E-values = 3.0e-2939 and 6.5e-1405, respectively; Figure
3D). The position weight matrix (PWM) for KLF1 bind-
ing is in perfect agreement with the motif identified in fetal
liver (CCM-CRC-CCN) (18) and otherKLFChIP-seq data
sets (17,20–22). We have reported the PWM in Figure 3D
based on the complementary strand (NGG-GYG-KGG)
to be consistent with structural studies of binding (8–14).
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Figure 1. Transcriptional dysregulation in Klf1Nan/+ fetal liver. (A) Proportional Venn diagram illustrating overlap between DEGs from Klf1Nan/+ and
Klf1−/− fetal liver compared to wild type controls. (B) Top five functional annotation gene ontology (GO) terms for each unique set of DEGs from
Klf1Nan/+ and Klf1−/− fetal liver. GO terms are ranked and displayed as -log10(Benjamini corrected P-value).
Thus, our system provides an accurate model of chromatin-
dependent KLF genome occupancy. Furthermore, Cent-
riMo analysis (52) shows a central enrichment of the iden-
tified PWM surrounding the peak summit for both Nan-
KLF1 and KLF1-occupied sites, which indicates the ChIP
has enriched for real binding events (Supplementary Figure
S2B and C).
Close inspection of the Nan-KLF1-occupied consensus
sequence (NGG-GMN-KGG) reveals aberrant specificity
at nucleotide positions 5 and 6 on the G-rich strand (un-
derlined above), consistent with the position of the muta-
tion in ZF2. There is altered specificity at position 5 from Y
(cytosine, thymine) to M (cytosine, adenosine) with a par-
ticular preference for C and a loss of specificity at position
6 (or position 4 on the complementary C-rich strand) from
predominantly G (guanine) to any nucleotide (Figure 3E).
Overall these results suggest a 2-fold increased specificity
at position 5, but 4-fold redundancy at position 6 for Nan-
KLF1 versus KLF1.
To further analyze the altered sequence specificity at po-
sitions 5 and 6, the central motif of every occupied site from
both Nan-KLF1 and KLF1 peak lists were placed into one
of 16 ‘bins’ based on the di-nucleotide sequence (Figure 3F
andG; Supplementary Table S2–S4). The CG di-nucleotide
was present in 42% and TG in 30% of the 3351 KLF1-only
occupied sites in vivo (Figure 3F), consistent with the PWM
derived fromMEME (Figure 3D) and our previous EMSA
data (26,30). In contrast, position 5–6 was CG in 17% and
TG in just 4% of the Nan-KLF1-only bound peaks (Figure
3G). This result supports a normal or mildly hypomorphic
function of Nan-KLF1 at some sites in the genome (Cat-
egory I sites such as the Alas2 first intron enhancer), and
severely hypomorphic or amorphic function at other sites
(Category II sites such as the Hbb gene promoter) (Figure
4A). Surprisingly, Nan-KLF1 peaks also exhibited a dra-
matic specificity shift to include any of AG, CA and CT
di-nucleotides at positions 5–6 (Figure 3G). This was un-
expected and is consistent with a neomorphic biochemical
function for the Nan-KLF1 protein.
Nan-KLF1 binds an altered sequence motif
To validate the aberrant binding specificity suggested by
ChIP-seq, we purified recombinant Nan-KLF1 and KLF1
ZF domains (see Methods). Correct folding of protein was
verified using circular dichroism (CD; Supplementary Fig-
ure S3). Data below 195 nmwere too noisy for reliable anal-
ysis due to buffer interference. Nevertheless, the CD spectra
indicated that both proteins are folded. Estimates of sec-
ondary structure, determined using the Dichroweb Server
(53) running the K2D method (54) from multiple data sets,
yielded estimates ranging between 20–30% helix and 20–
30% -sheet, consistent with the secondary structure con-
tent of similar proteins with the same folds.
We then tested the ability of the two ZF domains to bind
consensus sequences in vitro using EMSA. Binding to the
Hbb (Category II) probe by Nan-KLF1 was diminished in
comparison to KLF1, whereas binding to the Alas2 (Cate-
gory 1) probe was about equivalent (Figure 4A and B). This
result is consistent with our ChIP-seq data and previous
analyses (26,30). We also compared variants of the Alas2
probe where AG, CT and CA di-nucleotides were intro-
duced at position 5–6. Moderate binding to all Alas2 vari-
ants was observed for Nan-KLF1, while KLF1 bound only
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Figure 2. K1-NanER cell lines provide an in vitromodel of the Nan phenotype. (A) Schematic overview of the retroviral vector MSCV-Nan-KLF1-ER™-
IRES-GFP used to transduce K1 cells. The introduced Nan mutation (Glu339Asp) is indicated within the second ZF (dark blue bars) of KLF1. Nan-
KLF1 is expressed as an ER™ (striped bars) fusion protein. GFP; Green fluorescent protein, LTR; long-terminal repeat. (B) K1-NanER cells undergo less
hemoglobinization (pink pellet) than K1-ER cells (red pellet) following induction by 4-OHT for 48 h. (C) K1-ER cells show significant hemoglobinization
compared to ethanol treated controls, determined by the percentage of cells staining DAF positive within 48 h. Data are represented as mean ± SEM from
3 clonally independent cell lines. ***P < 0.001 (Student’s t-test). (D) Expression ofHbb-b1 and Ahsp following induction K1-ER and K1-NanER cells by
4-OHT as determined by qRT-PCR. Each point shown is the mean ± SEM for three clonally independent replicates normalized to the expression ofHprt
compared to parental K1 cells. *P < 0.05 for K1-NanER; #P < 0.05, ##P < 0.01 for K1-ER; †P < 0.05 for comparison between K1-NanER and K1-ER
(Student’s t-test). (E) Activation of Nan-KLF1 and KLF1 halts cell proliferation while Nan-KLF1 also reduces cell viability (n = 3 clonally independent
cell lines). Live cell count was performed using trypan blue exclusion. A two-way ANOVA with Bonferroni post-test correction was used to determine
significant differences between groups. Graphs show mean ± SEM. *P < 0.05, **P < 0.01 ***P < 0.001 for K1-NanER; #P < 0.05, ##P < 0.01 ###P <
0.001 for K1-ER; †P < 0.05, ††P < 0.01 †††P < 0.001 for comparison between K1-NanER and K1-ER.
AG weakly. Fluorescence polarization was used to mea-
sure the dissociation constant (KD) for each variant (Figure
4C). Nan-KLF1 (KD = 0.13 M) and KLF1 (KD = 0.15
M) showed equivalent affinity for the Alas2 probe. How-
ever, Nan-KLF1 affinity for AG, CT and CA was higher by
factors of ∼1.3, ∼2.9 and ∼1.6, respectively. This result is
consistent with the ChIP-seq data and demonstrates Nan-
KLF1 is able to bind these new sequences in vitrowith an en-
hanced affinity. Collectively, we refer to these new sequences
as category IV sites (Figure 4A). Although binding to aber-
rant sequences is weak in vitro, the binding affinity is suffi-
cient to detect as a ChIP-seq signal in many cases, but prob-
ably not all, as evidenced by the smaller number of MACS2
peaks passing our filters.
Glu339Asp is a conservative amino acid substitution and
so the profound impacts seen on KLF1 function associated
with this mutation were surprising. Two structures of KLF4
bound to a Category IDNAmotif are available (i.e. C at po-
sition 5 on the G-rich strand) (8,55). There is no reported
structure of KLF4-Category II DNA complex. KLF4 is
identical toKLF1 at all of theDNA-binding residueswithin
each of ZFs, and so serves as a goodmodel for KLF1-DNA
interactions. Arg336 and Arg342 in ZF2 of murine KLF1
(= Arg443 and Arg449 in KLF4) make hydrogen bonds
with the G-rich strand of the DNA consensus sequence at
G6 andG4, respectively (Figure 4D).Glu339 does notmake
direct contact with the C5 nucleotide but rather participates
in an extensive electrostatic network with Arg342, Asp338
(+2), a bound water molecule and the C5 nucleotide. To as-
sess the possible structural consequences of the Glu339Asp
mutation on DNA binding, we introduced this amino acid
substitution in silico into the KLF1-DNA structure (PDB
ID:2WBU). The orientation of the side chain was selected
from a rotamer library (40) to minimize steric clashes with
surrounding residues. As shown in Figure 4E, the shorter
aspartate sidechain is unlikely to be able to simultaneously
make all of the same interactions as Glu339. While it is not
possible to predict definitively the structural consequences
of this change, it is very likely that some reorganization of
the Arg336, Asp338 and Arg342 will take place. In turn,
such a reorganization could easily alter the DNA-binding
specificity of ZF2, consistent with the observed ChIP-seq
data.
Ectopic transcription is activated following ectopic Nan-
KLF1 binding to DNA
We next asked whether altered DNA-binding specificity
leads to an aberrant transcriptional response. To test this,
we employed 4-thiouridine (4sU)-RNA-seq, a robust and
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Figure 3. TheNanmutation (Glu339Asp) in ZF2 of KLF1 alters genome binding specificity. The E2f2 intronic enhancer andAhsp promoter are by bound
(A) KLF1 and (B) Nan-KLF1. ChIP was performed on 3 clonally independent K1-ER and K1-NanER cell lines with the following treatments serving
as controls: KLF1 Ab (+) or pre-immune serum (−), and treatment with 4-OHT (+) or ethanol (−) for 3 h. Enrichment of bound DNA was determined
by qPCR using primers targeted to KLF1 occupied sites (KBS). Regions ∼1 kb upstream and downstream serve as controls to ensure specificity for
Ab binding, and local chromatin state. (C) Proportional Venn diagram comparing the total number and overlap (red) of declared ChIP-seq peaks from
KLF1 (green) versus Nan-KLF1 (yellow). Lightly-shaded portions represent the intersection with DNase I hypersensitivity sites (DHS) contributed from
erythroid tissues/cells (combined total DHS = 295 322). Consensus binding motifs (or position weight matrix (PWM)) of (D) KLF1 and (E) Nan-KLF1
derived from declared peaks using de novo motif discovery (MEME). The Nan-KLF1 binding motif displays increased specificity at position 5 (*) and a
loss of specificity at nucleotide position 6 (#). Pie graphs displaying the proportions of each di-nucleotide found at position 5 and 6 in the central NGG-
GNN-KGG motif (found nearest to the summit) of unique (F) KLF1 and unique (G) Nan-KLF1 peaks. Only peaks containing an identified motif are
shown. The legend lists the nine most highly represented di-nucleotide combinations in each case. The color coding is maintained in subsequent figures.
reproducible method that captures newly synthesized RNA
through biotinylation of the incorporated uridine analog,
4sU (35).We utilized 4sU-RNA-seq to examine the immedi-
ate transcriptional response to a tamoxifen-induced KLF1-
DNA binding event (see Materials and Methods). We per-
formed qRT-PCR for primary pre-spliced RNA species
and fully processed RNA species derived from the Hbb-
b1 and Hprt genes that convincingly demonstrates that the
4sU-labeling and enrichment captures newly synthesized
RNA (Supplementary Figure S4A). Libraries were gener-
ated from 4sU-enriched RNA for sequencing on the Ion
Torrent Proton system.We collected greater than 25million
sequence reads from each sample including: (i) two clonally
independent replicates for K1-ER andK1-NanER cell lines
and (ii) two replicates of the parental line, K1 (as a nega-
tive control). Mapping of reads to mm9 identified levels of
intron coverage consistent with prior studies using a sim-
ilar 4sU-labeling period (35,56) and mRNA-seq (Supple-
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Figure 4. Differential binding by recombinant Nan-KLF1 and KLF1 zinc fingers in vitro. (A) Four categories of binding sites are differentially recognized
by Nan-KLF1 and KLF1. An expanded Table from Siatecka et al. (PNAS, 2010) reports binding (+) or lack of binding (−) to Category I–III sequences as
determined by electromagnetic shift assay (EMSA) (shaded rows). Binding of newCategory IV sequences are reported using a five-star scale (*= very weak
to ***** = very strong). (B) EMSA comparing complex formation between Nan-KLF1 or KLF1 ZF and radiolabeled dsDNA for known KLF1 binding
sites at Alas2 enhancer (Category I), Hbb promoter (Category II) and di-nucleotide variants of position 4–5 in Alas2 (Category IV). Equivalent amounts
of recombinant protein were loaded for each probe. (C) Binding affinities of Nan-KLF1 and KLF1 with oligos containing variant nucleotides at positions
5–6, as measured by fluorescence polarization assays. KLF1 affinities and curves are indicated in black, while Nan-KLF1 are color-coded according to the
probe used in A. (D) Model of the interaction of KLF1 ZF2 with DNA based on the structure of KLF4-DNA interactions (PDB ID: 2WBU). The basic
amino acids at positions −1 (Arg336) and +6 (Arg342) of the -helix form hydrogen bonds (blue dotted lines) with G6 and G4, respectively. Glu339 does
not make direct contact with C5. Instead, it forms a salt bridge with Arg342 and a hydrogen bond with an ordered water molecule found in the center of
the binding site (red sphere). Asp338 forms a hydrogen bond with the same water and a salt bridge with the sidechain of Arg336. (E) Model proposing the
likely structural consequence of the Glu339Asp Nan KLF1 mutation. The preferred sidechain orientation selected from a backbone dependent rotamer
library search suggests a significant change in orientation, such that residue 339 no longer interacts with Arg342 but instead is brought into close proximity
to Arg336 (green line), disrupting its interaction with G6 (red lines).
mentary Figure S4B). The alignment of sequenced tags was
largely to exons, suggesting co-transcriptional splicing is ef-
ficient within the 1 h labeling window, consistent with prior
studies on variability of rates of co-transcriptional splicing
(56–58).
To simplify the analysis, we counted tags over exons and
employed Cuffdiff (41) to findDEGs between parental (K1)
and K1-ER or K1-NanER cell lines. The two replicates for
each cell line were highly correlated (Supplementary Figure
S4C), with a Spearman’s correlation coefficient great than
0.95 across sample groups. Comparing the magnitude of
fold change between KLF1 and Nan-KLF1 DEGs shows
most DEGs are differentially responsive between sample
groups (Figure 5A). For example, some known KLF1 tar-
get genes, such as Alas2 (26) and Klf10 (59), are acti-
vated equally (4.4-fold and ∼100-fold up-regulated respec-
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Figure 5. 4sU-RNA-seq reveals a corrupted transcriptome in K1-NanER cells. (A) Scatter plot representation of DEGs in K1-ER and K1-NanER cells
compared to the parental K1 cells. Each data point represents a single RefSeq gene plotted according to the log2(fold change) between K1-ER/K1 (x-axis)
and the log2(fold change) between K1-NanER/K1 (y-axis). Specific data point referring to genes of interest have been highlighted in red and annotated
accordingly. (B) Proportional Venn diagram displaying the overlap between DEGs in two clonally independent K1-ER andK1-NanER cell lines compared
to replicate parental K1 cells following 1 h of tamoxifen induction. (C) Validation of primary transcript expression by qRT-PCR from two independent
K1-ER (clone A and C) and two K1-NanER (clone B and X) cell lines illustrates both hypomorphic and neomorphic regulation of target genes by Nan-
KLF1. Expression was normalized to Hprt primary transcript (that does not change in absolute FPKM values between groups) using the Ct method
comparing tamoxifen and ethanol treated controls.
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tively) by KLF1 and Nan-KLF1, while other KLF1 target
genes such as Alad (60) and Hbb-b1 (15) are more respon-
sive to KLF1. Finally a third set of genes, not regulated
by KLF1, are responsive to Nan-KLF1; this set includes
Dusp7, Sh3bp1 andZfp36. Expression of these genes is con-
sistent with a neomorphic function for Nan-KLF1.
In total, we found significant activation of 589 genes and
repression of 180 genes by KLF1, whereas Nan-KLF1 in-
duced 735 genes and repressed 442 genes (Supplementary
Table S5 and S6). The overlap between these DEGs have
been represented by a Venn diagram in Figure 5B. A fur-
ther 8227 non-differentially expressed genes were identified
(using a cutoff for expression of >1 FPKM), suggesting
KLF1 regulates about 9% of the erythroid gene repertoire
in proerythroblasts.
We validated the 4sU-RNA-seq data by qRT-PCR on
4sU-RNA using primers designed to detect primary pre-
spliced transcripts (Figure 5C). The trends observed for the
qRT-PCR data mirror those observed in the 4sU-RNA-seq
data, and highlight both the hypomorphic and neomorphic
functions of Nan-KLF1 at different genome locations or
contexts.
Differential Nan-KLF1 occupancy is co-incident with ectopic
gene expression
To gain further insight at specific gene loci, we inspected
genes from each of the activated groups using the UCSC
Genome Browser (Figure 6).Alas2 is the first enzyme in the
heme biosynthetic pathway and a known KLF1 target gene
(26). Nan-KLF1 andKLF1 both bound strongly in the first
intron of Alas2, co-incident with strong transcriptional ac-
tivation (∼4.5-fold) by both (Figure 6A). The central motif
identified in both ChIP-seq data sets contains the CG di-
nucleotide (Category I motif), consistent with the ability of
both Nan-KLF1 and KLF1 to bind this sequence by ChIP-
seq.
Alad encodes the second enzyme of the heme biosynthetic
pathway and is also directly activated by KLF1 (60). KLF1
binds strongly to the middle of intron 1, and this overlaps
a DHS in fetal liver (Figure 6B). We found no evidence
forNan-KLF1 binding. Furthermore,KLF1 activates tran-
scription robustly (blue track) whereas Nan-KLF1 does
so poorly (red track), similar to parental K1 cells (pur-
ple track). The motif bound by KLF1 in the Alad intron
is an example of a Category II motif, containing the di-
nucleotide TG. Again, this result is consistent with reduced
binding and a hypomorphic function of Nan-KLF1 at Cat-
egory II sites.
Lastly, we find the altered motif specificity of Nan-
KLF1 leads to aberrant binding within the second in-
tron of Sh3bp1. This is a novel binding site, with no evi-
dence of DHS in erythroid cells, nor KLF1 binding (Fig-
ure 6C). The central motif of this peak contains an CT di-
nucleotide; i.e. it is an example of a Category IV motif (Fig-
ure 4A). Sh3bp1 is ectopically activated by Nan-KLF1; it
is a RhoGAP protein normally expressed by neural tissues
(Figure 5C) (61). Expression in erythroid cells has not pre-
viously been reported and aberrant expression could lead to
dysregulated signaling. Similarly, upregulation of the dual-
specificity phosphatase, Dusp7 (Figure 5C), could lead to
downregulation of p38-MAP kinase signaling (an EpoR-
activated pathway). Also, upregulation of Zfp36 (Figure
5C) could induce a signal to proliferate as it might mimic
a steroid hormone receptor signaling pathway that works
via a related protein, ZFP36L2 (62).We propose that a suite
of suchNan-KLF1-activated genes are together responsible
for erythroid cell toxicity and the semi-dominant anemia.
Although these genes are sometimes upregulated in stress
responses, they are still likely to be direct targets of Nan-
KLF1 with differential occupancy found in the promoter
or upstream of both genes (Supplementary Figure S5).
Exploring the relationship between aberrant Nan-KLF1
binding and ectopic gene regulation at the genome-wide
level we find 205 KLF1 promoter peaks within KLF1
DEGs (28%) and 102 Nan-KLF1 promoter peaks within
the Nan-KLF1 DEGs (9%). This strongly implies direct
regulation of these genes. However, KLF1 is also known
to bind enhancers that may be located distally (>1 kb) or
within other genes (18). To investigate possible distal regu-
lation of DEGs, we plotted the fold change of each DEG,
together with the distance to the nearest to ChIP-seq peak
as a ‘four-dimension bubble plot’ for both Nan-KLF1 and
KLF1. The concept is similar to that employed by Soler et
al. (63). The fold enrichment and di-nucleotides at positions
5–6 of each peak’s central motif were included by adjusting
the size and color of each data point (Figure 7).
This multi-dimensional comparison provides useful in-
sight into the underlying mechanism by which theNanmu-
tation exerts both repressive and neomorphic effects on the
erythroid genome. The most obvious perturbation is a shift
in the central motif category (color). For example, peaks
closest to Nan-KLF1 DEGs show a marked increase in
the proportion of CT, or CA di-nucleotides (Category IV
sites) and a loss of the TG di-nucleotide (Category II sites)
compared with peaks closest to KLF1 DEGs. This is illus-
trated by the shift in bubble color from blue and green for
KLF1-responsive genes to blue, orange and red for Nan-
KLF1-responsive genes. Also, while KLF1 is almost exclu-
sively a transcriptional activator, a large proportion of genes
are repressed by Nan-KLF1 (found below x-axis). The ma-
jority of these genes are not KLF1 targets. Lastly, Nan-
KLF1 binding sites are sometimes found more distant to
the nearest regulated TSS (both activated and repressed).
This suggests they are not directly regulated or are distally
regulated by Nan-KLF1. This could occur if Nan-KLF1
blocked binding of other erythroid transcription factors, or
disrupted enhancer-promoter interactions (e.g. via block-
ing of DNA looping). We propose a model whereby ec-
topic binding of Nan-KLF1 not only directly drives aber-
rant gene transcription, but sometimes indirectly disrupts
the activity ofKLF1-independent erythroid genes or house-
keeping genes.
DISCUSSION
We have demonstrated the transcriptome of Klf1Nan/+ fe-
tal liver is aberrant, since the majority of DEGs are not
normal KLF1 target genes. This lead to the hypothesis
that Nan-KLF1 must have a detrimental gain of function.
To dissect this without confounding effects from wild-type
KLF1, we developed an in vitro model system where we
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Figure 6. Nan-KLF1 binding is co-incident with ectopic gene regulation at specific loci. Images from themurineUCSCGenome Browser with read density
graphs (wiggle plots) displaying KLF1 ChIP-seq, and 4sU-RNA-seq from representative K1, K1-ER andK1-NanER cell lines following 4-OHT treatment
and DHS tracks from E14.5 FL (yellow). Additional tracks depict the di-nucleotide sequence and peak summit location for significantly enriched peaks.
4sU-RNA-seq reads mapping to the Crick strand are displayed as negative values in wiggle plots. (A) Alas2 locus depicting transcriptional activation by
both Nan-KLF1 and KLF1 co-incident with binding of both Nan-KLF1 (orange track) and KLF1 (green track) within the first intron. ChIP peaks at this
location share a common centralmotif containing the di-nucleotideCG (Category I site), and they overlap aDHS in fetal liver (yellow track). There is robust
induction of transcription for both K1-ER and K1-NanER cells (blue and red tracts) compared to parental K1 cells (purple track). (B) The Alad locus is
activated and primarily bound byKLF1. The largest peak in the first intron overlaps withDHS and contains the TG central di-nucleotide (Category II site).
It is not bound by Nan-KLF1 and there is minimal activation of Alad transcription by Nan-KLF1. (C) Ectopic binding and transcriptional activation of
Sh3bp1 by Nan-KLF1. The peak in the second intron (Category IV) does not display DHS in fetal liver nor is it bound by KLF1. Nevertheless, Nan-KLF1
binds this site robustly in vivo and results in Nan-KLF1-specific transcriptional activation.
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Figure 7. Global changes in aberrant gene regulation are associated with genome-wide corruption of DNA-binding specificity. Bubble plot representation
of (A) KLF1 and (B) Nan-KLF1 binding sites in the neighborhood of DEGs between (A) K1-ER or (B) K1-NanER compared to K1 (parental) cell
lines. Each data point is displayed to represent four parameters of a DEG: distance to the nearest ChIP-seq peak (x-axis), log2(fold change) (y-axis), fold
enrichment of tag count over the ChIP-seq peak compared with input DNA (bubble diameter) and central motif di-nucleotide (bubble color).
could induce expression of either version of KLF1 on a
Klf1−/− genetic background but in an erythroid context.
Using ChIP-seq, we showed the Glu339Asp mutation al-
ters the DNA-binding specificity of KLF1 in a complex and
context-dependent manner. We confirmed Nan-KLF1 has
less affinity for a T at position 5 in the consensus motif in
vivo as it does in vitro (30).We also demonstrated a dramatic
and surprising loss of specificity at position 6. Whereas
KLF1 only binds G, Nan-KLF1 binds A, G or T at this
position in vitro and in vivo. The use of 4sU-labeling of
newly synthesized RNA facilitated the detection of imme-
diate transcriptional events following specific activation of
either version ofKLF1. In combinationwith the tamoxifen-
inducible expression system andChIP-seq, 4sU-RNA-seq is
a powerful and sensitive technique for interrogating the di-
rect transcriptional consequences of altering the TF-DNA-
interaction code. It will be generally applicable to the analy-
sis of any rapid transcriptional responses to external signals,
transcription factor or splicing factor modifications.
The motif degeneracy observed at position 6 in the Nan-
KLF1 PWM should theoretically increase the number of
possible binding sites genome-wide (by 4-fold, since each
nucleotide could be observed at this position), but in prac-
tice it leads to a reduction in total detectable peaks called
from ChIP-seq data. The most likely explanation is that
there is a reduction in overall binding affinity, as suggested
by our EMSA data, such that many binding events fall
below the detection threshold of ChIP. Nevertheless, the
transcriptional changes are consistent with meaningful low
affinity occupancy at aberrant sites that outnumber normal
sites due to degenerate binding specificity. This has impor-
tant implications for our understanding of disease-causing
mutations in ZF transcription factors.
A dominant mutation in human KLF1 at the equiva-
lent residue, Glu325Lys (DNA-contacting position +3 in
ZF2) results in congenital dyserythropoietic anemia (64).
Although not yet tested, it is likely this mutation also causes
a gain of function altering DNA-binding specificity. There
are other reported missense mutations in KLF1 at key
DNA-contact residues in ZF1 at +6 (Ala298Pro) and ZF2
at +6 (Arg328His and Arg328Leu), which could also re-
sult in neomorphic as well as hypomorphic functions (65–
67). Since ZFPs are the most common class of proteins en-
coded in themammalian genome, it is likely that this type of
neomorphic mutation occurs in other transcription factors.
Indeed, there is a reported dominant mutation in ZF1 of
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murineKLF3 (H275R at +3), which leads to dominant con-
genital heart disease (68). Barrera et al. recently identified
thousands of human alleles from publicly available genome
sequencing projects that are likely to alter DNA binding of
various TFs (69). Many of these alleles are Mendelian dis-
ease mutations (69). We believe our analysis of Nan-KLF1
in vivo binding site preferences and the consequences for cell
function is the first for such a disease-associated allele. It
will provide a template for further similar studies of the ef-
fects of DNA-contact mutations in other ZFPs and in dif-
ferent cellular contexts.
Our initial prediction of the disease mechanism under-
pinning the Nan mutation, based upon extensive in vitro
binding data, turned out to be incorrect. We found the +3
amino acid in ZF2 ofKLF1 plays an important indirect role
in determining the interaction between the −1 amino acid
and DNA. However, our data are, in fact, consistent with
previous studies that were designed to select the most fa-
vorable amino acid combinations at positions −1, +2, +3
and +6 in C2H2 fingers for binding to DNA triplets. These
studies suggest amino acids at these four positions work
together to confer DNA-binding specificity; i.e. they work
as a module to define DNA-binding specificity rather than
work independently (4). We suggest there may be different
ZF-DNA conformations which reflect the precise preferred
DNA-sequence; i.e. whether an T or C resides at position
6 (for ZF2) and whether an T or G resides at position 8
(for ZF1). Although a great deal can be predicted (3), fur-
ther ChIP-seq studies are required to investigate natural
or engineered mutations at other critical DNA-contacting
amino acids to fully understand the DNA interaction code
of ZFPs. These studies will complement the extensive in
vitro data we currently use for predicting binding specificity
of mutant TFs and the design of engineered ZF (3,70).
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